Available online on 15.12.2024 at ijmspr.com

 International Journal of Medical Sciences and Pharma Research 

Open Access to Medical Science and Pharma Research

Copyright  © 2024 The   Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited

Open Access                                                                                                                                                                                                                   Review Article

Insights into Maternal Health: Mentzer Index for Early Anemia Detection

Emmanuel Ifeanyi Obeagu ¹* and Getrude Uzoma Obeagu ²

¹ Department of Medical Laboratory Science, Kampala International University, Uganda.

² School of Nursing Science, Kampala International University, Uganda.

 

 

Introduction

Anemia during pregnancy is a prevalent global health issue, affecting approximately 38% of pregnant women and posing serious risks to maternal and fetal health. It is characterized by a deficiency of red blood cells or hemoglobin, leading to reduced oxygen delivery to body tissues. The primary causes of anemia in pregnant women include iron deficiency and inherited hemoglobinopathies like thalassemia. Given that anemia can result in complications such as preterm birth, low birth weight, and increased maternal mortality, early and accurate diagnosis is essential for effective intervention. In this context, hematological indices such as the Mentzer Index have proven invaluable in identifying anemia subtypes, especially in resource-limited settings where advanced testing may not be readily available.^1-2 The Mentzer Index, introduced by William Mentzer, is a straightforward calculation involving two commonly assessed blood parameters: mean corpuscular volume (MCV) and red blood cell (RBC) count. By dividing MCV by RBC count, the Mentzer Index helps differentiate between iron deficiency anemia and thalassemia, two types of anemia with distinct treatment approaches. An index value greater than 13 typically points toward iron deficiency anemia, while a value below 13 suggests a thalassemia trait. This clear distinction is crucial, as iron deficiency anemia often responds well to iron supplementation, whereas individuals with thalassemia may require more specialized management strategies.^3-4 Anemia poses a significant risk to maternal health, leading to symptoms such as fatigue, dizziness, and an increased likelihood of complications during delivery. Untreated anemia can worsen over the course of pregnancy, especially as blood volume increases, placing further strain on the mother’s cardiovascular system. Iron deficiency anemia is particularly concerning as it depletes essential nutrients needed for fetal growth and development. Meanwhile, conditions like thalassemia require careful monitoring and sometimes necessitate interventions like blood transfusions to manage severe cases. The Mentzer Index can help detect these conditions early, allowing for timely management that minimizes health risks for both mother and child.^5-6

Beyond maternal health, anemia during pregnancy can have significant impacts on fetal outcomes. Infants born to mothers with untreated anemia are at higher risk for low birth weight, preterm birth, and developmental delays. Early detection of anemia through tools like the Mentzer Index offers an opportunity to address these risks proactively, improving fetal growth conditions. In particular, by distinguishing between iron deficiency anemia and thalassemia, healthcare providers can ensure that pregnant women receive the most appropriate treatment, thus promoting healthier fetal development and reducing complications associated with untreated anemia.^7-8 The Mentzer Index’s simplicity makes it especially valuable in low-resource settings where access to advanced laboratory tests may be limited. In regions where thalassemia and iron deficiency anemia are both prevalent, such as Southeast Asia, the Mediterranean, and parts of Africa, this tool serves as an accessible and cost-effective means of initial screening. Through routine blood tests often available in prenatal care, the Mentzer Index can be calculated quickly, empowering healthcare providers to make informed decisions about further testing and treatment. This advantage is crucial in underserved areas, where early anemia detection can be a determining factor in maternal and neonatal health outcomes.^9-10 Several other hematological indices, such as the red cell distribution width index (RDWI) and the Shine and Lal index, are also used to help identify anemia types. However, the Mentzer Index is particularly popular due to its ease of calculation and reasonable accuracy in distinguishing iron deficiency anemia from thalassemia. While these indices are not without limitations, their utility in a variety of clinical settings underscores the growing recognition of simple hematological markers as frontline tools in anemia detection and management. The Mentzer Index’s reliability in diverse healthcare contexts highlights its role as a valuable tool in the global effort to combat maternal anemia.¹¹ Despite its advantages, the Mentzer Index has some limitations, particularly in cases with borderline MCV or RBC values. Additionally, the hemodilution that naturally occurs in pregnancy can impact RBC indices, potentially affecting the accuracy of the Mentzer Index. Thus, while the Mentzer Index is a useful preliminary tool, supplementary testing is often required for a definitive diagnosis. However, when used as an initial screening measure, the Mentzer Index remains a practical and efficient means of identifying potential anemia cases, providing critical early insights into maternal health conditions that may require further evaluation.¹²

Understanding the Mentzer Index

The Mentzer Index is a simple, calculated hematological parameter that assists in distinguishing between types of anemia, specifically iron deficiency anemia and thalassemia. Proposed by Dr. William Mentzer, this index is obtained by dividing the mean corpuscular volume (MCV) by the red blood cell (RBC) count. The primary clinical value of the Mentzer Index lies in its ability to differentiate between two common causes of microcytic anemia. Typically, a Mentzer Index greater than 13 suggests iron deficiency anemia, while a value less than 13 is more indicative of thalassemia. This distinction is essential because these conditions require different treatment approaches; iron supplementation can improve iron deficiency anemia, whereas thalassemia may necessitate specialized care such as blood transfusions and genetic counseling.¹³ In practice, the Mentzer Index is especially valuable due to its simplicity and the accessibility of MCV and RBC count data from a standard complete blood count (CBC) test. Unlike more complex or costly diagnostic procedures, which may not be available in low-resource settings, the Mentzer Index can be calculated quickly with basic lab equipment. This ease of calculation makes it a powerful initial screening tool for anemia, particularly in regions with limited healthcare resources where both iron deficiency and thalassemia are prevalent.¹⁴ The effectiveness of the Mentzer Index in detecting anemia types stems from the distinct differences in red blood cell production in iron deficiency anemia and thalassemia. In iron deficiency anemia, MCV tends to be reduced, but RBC count does not rise proportionally, resulting in a higher Mentzer Index. In contrast, thalassemia is characterized by a relatively high RBC count in comparison to MCV, leading to a lower Mentzer Index. Thus, by evaluating these hematological differences, healthcare providers can make informed diagnostic decisions and pursue targeted treatment pathways.¹⁵

Despite its strengths, the Mentzer Index does have limitations. Its reliability may decrease in cases of complex anemia with overlapping etiologies or in patients with borderline values of MCV and RBC count. Additionally, pregnancy-related hemodilution—where increased plasma volume dilutes red blood cell concentrations—can impact RBC indices, potentially leading to less accurate Mentzer Index calculations. As a result, while the index serves as a valuable initial screening tool, further diagnostic testing, such as serum ferritin measurements or hemoglobin electrophoresis, is often required for a conclusive diagnosis.¹⁶ Comparisons with other indices, such as the red cell distribution width index (RDWI) and the Shine and Lal index, suggest that while each index has unique diagnostic strengths, the Mentzer Index remains particularly useful due to its ease of calculation and reasonably high accuracy in differentiating between iron deficiency anemia and thalassemia. Studies have shown that in many clinical settings, the Mentzer Index maintains reliable performance in identifying anemia types and is often incorporated into routine blood analysis.

Relevance of Early Anemia Detection in Maternal Health

Early detection of anemia is critical in maternal health due to its profound effects on both maternal and fetal well-being. Anemia, particularly iron deficiency anemia, is one of the most prevalent health issues affecting pregnant women worldwide, and its consequences can be severe if left untreated. Early detection can help prevent a range of complications, from fatigue and decreased immunity in mothers to developmental challenges and preterm birth risks for the baby. Screening tools such as the Mentzer Index, which helps differentiate iron deficiency anemia from thalassemia, are particularly beneficial in allowing for early diagnosis and appropriate management.¹⁷ Anemia during pregnancy can lead to several maternal health complications. Women with untreated anemia may experience increased fatigue, shortness of breath, and weakened immune function, which can diminish their ability to handle the physical demands of pregnancy and childbirth. Severe cases of anemia are associated with higher risks of maternal mortality, as well as postpartum hemorrhage, one of the leading causes of maternal death. Fetal health is also closely tied to maternal hemoglobin levels. Infants born to anemic mothers are at higher risk of low birth weight, preterm birth, and impaired neurodevelopment. Inadequate oxygen delivery to the fetus due to anemia in the mother can negatively affect fetal growth and increase the likelihood of developmental delays. Early anemia screening, through indices like the Mentzer Index, ensures that any form of anemia is identified and addressed before it impacts fetal health, promoting better birth outcomes and reducing neonatal morbidity and mortality. In addition to physical health, anemia can affect maternal mental health, which is crucial for maternal and neonatal outcomes. Studies show that anemia can increase the likelihood of depression and anxiety in pregnant women. Early anemia detection can prevent these mental health challenges, as treatment for anemia may also help improve emotional well-being, leading to more positive maternal experiences and better maternal-infant bonding.¹⁸

Screening for anemia early in pregnancy is especially relevant in areas with limited healthcare resources. Many regions with high rates of maternal anemia lack advanced diagnostic tools, making simple and accessible screening methods, like the Mentzer Index, invaluable. In these settings, early detection enables targeted interventions, such as iron supplementation, dietary counseling, and more specialized care when conditions like thalassemia are identified. These proactive steps can prevent severe anemia cases, reducing healthcare costs and improving long-term health outcomes for mothers and children. The benefits of early anemia detection extend into the postpartum period. Women who are anemic during pregnancy often face prolonged recovery times after childbirth and are more susceptible to postpartum depression and delayed wound healing. By identifying and managing anemia early, healthcare providers can enhance recovery prospects for new mothers, ensuring they have the strength and well-being necessary for caring for their newborns.¹⁹

Mentzer Index Application in Clinical Settings

The Mentzer Index, a simple but effective diagnostic tool, is widely applied in clinical settings to differentiate between iron deficiency anemia and thalassemia. By calculating the ratio of mean corpuscular volume (MCV) to red blood cell (RBC) count, the Mentzer Index allows healthcare professionals to distinguish between these two types of microcytic anemia, each of which requires different treatments. This method is particularly valuable as it leverages readily available data from a complete blood count (CBC) test, making it an accessible option in both well-equipped hospitals and low-resource clinical environments.¹⁰ In primary healthcare settings, the Mentzer Index serves as a quick screening tool, guiding initial decisions on further testing and management. When a patient presents with symptoms of anemia—such as fatigue, pallor, or shortness of breath—obtaining a CBC is often the first step. Using the Mentzer Index, providers can rapidly evaluate the likelihood of iron deficiency anemia (with an index value typically >13) or thalassemia (with an index value <13). This preliminary screening helps clinicians decide if the patient requires dietary iron supplementation or more specialized testing for hemoglobinopathies, conserving resources and improving treatment efficiency.¹¹ For obstetricians managing pregnant patients, the Mentzer Index is particularly relevant. Anemia during pregnancy can lead to complications for both the mother and fetus, including preterm delivery and low birth weight. In pregnant patients with microcytic anemia, distinguishing iron deficiency from thalassemia is essential, as iron supplementation—commonly given in cases of iron deficiency—can be ineffective or even counterproductive in individuals with thalassemia. By employing the Mentzer Index early in prenatal care, obstetricians can ensure that the right diagnostic and therapeutic pathways are chosen, thereby safeguarding maternal and fetal health.¹²

In pediatric care, the Mentzer Index aids in the early diagnosis of thalassemia in young children. Since thalassemia is often hereditary, early detection through routine bloodwork enables parents and caregivers to understand their child's condition and begin appropriate management strategies. Pediatricians can use the Mentzer Index to distinguish between nutritional anemia and genetic conditions, informing whether to recommend iron supplementation or refer the child for genetic counseling and further testing.¹³ In resource-limited clinical settings, particularly in developing countries where both iron deficiency and thalassemia are common, the Mentzer Index is a valuable tool. Access to advanced diagnostic tools, such as hemoglobin electrophoresis, may be limited in these settings. By utilizing the Mentzer Index, healthcare providers can conduct preliminary assessments to determine the most likely cause of anemia and prioritize resources for those needing specialized care. This targeted approach maximizes the impact of available resources, helping underserved populations receive more precise and timely treatment.¹⁴ The Mentzer Index also has a role in hematology and oncology clinics, where anemia can present as a secondary symptom in various conditions. For example, patients undergoing chemotherapy often experience anemia, and a Mentzer Index calculation can help identify whether the anemia is due to iron deficiency or an underlying thalassemia trait. This differentiation informs treatment decisions and ensures that anemia is managed appropriately without unnecessary interventions that could affect patient recovery.¹⁵

Comparison of Mentzer Index with Other Indices

The Mentzer Index is one of several hematological indices used in the differential diagnosis of microcytic anemias, particularly in distinguishing iron deficiency anemia from thalassemia. Other indices, such as the Shine and Lal Index, the Red Cell Distribution Width Index (RDWI), and the Green and King Index, serve similar purposes but with varying degrees of accuracy, complexity, and applicability. While each of these indices has its strengths, the Mentzer Index remains one of the most widely used due to its simplicity and reliability in primary and resource-limited healthcare settings.¹⁶ The Mentzer Index is calculated by dividing the mean corpuscular volume (MCV) by the red blood cell (RBC) count. A Mentzer Index greater than 13 is indicative of iron deficiency anemia, whereas a value below 13 suggests thalassemia. The simplicity of the Mentzer Index makes it highly accessible, especially in settings where additional diagnostic tools may be limited. However, its specificity can decrease in cases with overlapping anemia types or unusual hematological profiles, such as combined iron deficiency and thalassemia.¹⁷ A Shine and Lal Index value above 1530 is typically indicative of thalassemia. This index offers higher sensitivity for detecting thalassemia, particularly in cases where MCV alone might be misleading due to coexisting nutritional deficiencies. However, the Shine and Lal Index requires more detailed calculations, which can be impractical in routine settings or low-resource areas, making it less accessible than the Mentzer Index. The Red Cell Distribution Width Index (RDWI) is another useful parameter, with RDW representing red cell distribution width. RDWI is beneficial in distinguishing between iron deficiency anemia and thalassemia trait, as a value above 220 suggests iron deficiency anemia, while a lower value suggests thalassemia. RDWI has the advantage of incorporating RDW, which reflects variability in red cell size and can provide insights into red cell production abnormalities. This index may offer slightly higher accuracy in differentiating anemias; however, it requires RDW data, which may not be available in all standard CBC reports, especially in basic or low-cost healthcare environments.¹⁷

The Green and King Index value is typically higher in thalassemia than in iron deficiency anemia, with cut-off points aiding in differentiation. This index takes into account the mean corpuscular hemoglobin concentration (MCHC), which can add to its sensitivity for thalassemia. However, the complexity of its calculation limits its routine use, as it may be challenging to perform without automated systems or access to electronic calculation aids. A comparative analysis of these indices shows that while the Mentzer Index is more straightforward and quick to calculate, indices like RDWI and Shine and Lal may offer higher specificity for thalassemia in cases where anemia types overlap or present with atypical red cell indices. The Mentzer Index’s strength lies in its accessibility and applicability in a broad range of settings, from primary healthcare centers to rural clinics, where its simplicity enables prompt initial screening. In clinical settings that have access to advanced hematological analysis, combining indices—such as using both the Mentzer Index and RDWI—can enhance diagnostic accuracy, especially in complex cases. By cross-referencing results from multiple indices, healthcare providers can more confidently distinguish between anemia types and tailor treatments accordingly. However, for quick screening purposes or in environments with limited resources, the Mentzer Index is often the preferred choice due to its balance of simplicity and effectiveness.^17-18

Challenges and Limitations

While the Mentzer Index is widely used in clinical settings due to its simplicity, it has several limitations and challenges that can impact its accuracy and reliability in anemia diagnosis. One of the primary challenges is its reduced sensitivity and specificity in cases where patients have overlapping types of anemia, such as iron deficiency combined with thalassemia trait. Since the Mentzer Index relies solely on the mean corpuscular volume (MCV) and red blood cell (RBC) count, it does not account for complexities in hematological profiles that may result from coexisting conditions, which can skew the index value and lead to misclassification. Another limitation of the Mentzer Index is its susceptibility to variation due to external factors affecting MCV and RBC counts. For example, pregnancy-induced hemodilution and certain chronic illnesses can alter these values, leading to misleading Mentzer Index results. In such cases, relying on this index alone may not provide an accurate picture of the patient's anemia type, necessitating additional tests, such as serum ferritin for iron deficiency or hemoglobin electrophoresis for thalassemia. This need for complementary testing can present a barrier in low-resource settings where such additional diagnostic options may be limited or unavailable.¹⁹ Age-related variations in MCV and RBC counts present further challenges, especially in pediatric populations. The normal ranges for these values can differ significantly between children and adults, which may reduce the accuracy of the Mentzer Index in diagnosing anemia in younger patients. Infants and young children, who are often vulnerable to both iron deficiency and genetic forms of anemia, may present with atypical RBC values, complicating the use of the Mentzer Index in isolation. In such cases, age-specific reference ranges are essential for accurate interpretation, but these are not always readily accessible in all clinical settings.

Another drawback of the Mentzer Index is its reliance on a single threshold cut-off of 13, which may not apply universally across different ethnic groups or populations. Variability in hematological parameters across populations can affect MCV and RBC values, which in turn impacts the Mentzer Index's effectiveness in distinguishing iron deficiency from thalassemia in diverse patient populations. Studies indicate that certain populations may naturally exhibit variations in MCV and RBC levels, potentially leading to false positives or negatives if the Mentzer Index threshold is applied without adjustment. This suggests a need for population-specific studies to validate the Mentzer Index’s cut-off values for more accurate clinical application. In addition, there is the challenge of differentiating the Mentzer Index values in patients with non-typical presentations of anemia, such as those with chronic inflammatory conditions or those undergoing certain medications that may alter RBC indices. These cases can complicate the interpretation of the Mentzer Index, as such conditions may mask or mimic the hematological profile of iron deficiency anemia or thalassemia. Clinicians may need to be aware of these potential influences to avoid diagnostic errors, particularly in patients with complex medical histories. In low-resource settings, a limitation of the Mentzer Index is the reliance on accurate RBC counts, which may vary due to outdated equipment or lack of quality control in hematological testing. Inaccurate readings can lead to miscalculations, reducing the reliability of the Mentzer Index as a diagnostic tool. Furthermore, many primary care facilities in these settings may not have routine access to CBC machines, limiting the widespread applicability of the Mentzer Index as an initial screening tool for anemia.^18-19

Conclusion

The Mentzer Index remains a practical and accessible tool for the initial differentiation of microcytic anemias, particularly for distinguishing between iron deficiency anemia and thalassemia. Its simplicity and reliance on basic hematological parameters, such as mean corpuscular volume (MCV) and red blood cell (RBC) count, make it valuable in primary healthcare settings and in regions where advanced diagnostic facilities may be limited. By providing a quick and cost-effective method for anemia classification, the Mentzer Index plays a crucial role in guiding early treatment decisions, helping clinicians promptly identify appropriate care pathways. However, the Mentzer Index is not without limitations. Factors such as age, ethnicity, and coexisting health conditions can affect its accuracy, and it may not perform well in cases of overlapping anemia types or where additional red cell indices are abnormal. Therefore, while the Mentzer Index serves as a useful preliminary tool, its results are most reliable when used in conjunction with other diagnostic methods, such as serum ferritin levels, RDW, and hemoglobin electrophoresis, for a more comprehensive assessment.

Conflict of Interest: The authors declare no potential conflict of interest with respect to the contents, authorship, and/or publication of this article.

Author Contributions: All authors have equal contribution in the preparation of manuscript and compilation.

Source of Support: Nil

Funding: The authors declared that this study has received no financial support.

Informed Consent Statement: Not applicable. 

Data Availability Statement: The data supporting in this paper are available in the cited references. 

Ethics approval: Not applicable.

References

1. Rahman MM, Abe SK, Rahman MS, Kanda M, Narita S, Bilano V, Ota E, Gilmour S, Shibuya K. Maternal anemia and risk of adverse birth and health outcomes in low-and middle-income countries: systematic review and meta-analysis. The American journal of clinical nutrition. 2016; 103(2):495-504. https://doi.org/10.3945/ajcn.115.107896 PMid:26739036

2. Obeagu EI, Ezimah AC, Obeagu GU. Erythropoietin in the anaemias of pregnancy: a review. Int J Curr Res Chem Pharm Sci. 2016;3(3):10-8. https://doi.org/10.22270/ijmspr.v10i2.95

3. Okamgba OC, Nwosu DC, Nwobodo EI, Agu GC, Ozims SJ, Obeagu EI, Ibanga IE, Obioma-Elemba IE, Ihekaire DE, Obasi CC, Amah HC. Iron Status of Pregnant and Post-Partum Women with Malaria Parasitaemia in Aba Abia State, Nigeria. Annals of Clinical and Laboratory Research. 2017;5(4):206.

4. Petrakos G, Andriopoulos P, Tsironi M. Pregnancy in women with thalassemia: challenges and solutions. International journal of women's health. 2016:441-451. https://doi.org/10.2147/IJWH.S89308 PMid:27660493 PMCid:PMC5019437

5. Obeagu EI, Adepoju OJ, Okafor CJ, Obeagu GU, Ibekwe AM, Okpala PU, Agu CC. Assessment of Haematological Changes in Pregnant Women of Ido, Ondo State, Nigeria. J Res Med Dent Sci. 2021 Apr;9(4):145-8.

6. Agreen FC, Obeagu EI. Anaemia among pregnant women: A review of African pregnant teenagers. Journal of Public Health and Nutrition. 2023;6(1):138.

7. Arora S, Rana D, Kolte S, Dawson L, Dhawan I. Validation of new indices for differentiation between iron deficiency anemia and beta thalessemia trait, a study in pregnant females. International Journal of Scientific Reports. 2018; 4(2):26. https://doi.org/10.18203/issn.2454-2156.IntJSciRep20180394

8. Tabassum S, Khakwani M, Fayyaz A, Taj N. Role of Mentzer index for differentiating iron deficiency anemia and beta thalassemia trait in pregnant women. Pakistan Journal of Medical Sciences. 2022;38(4Part-II):878. https://doi.org/10.12669/pjms.38.4.4635

9. Matos JF, Dusse LM, Stubbert RV, Ferreira MR, Coura-Vital W, Fernandes AP, de Faria JR, Borges KB, Carvalho MD. Comparison of discriminative indices for iron deficiency anemia and β thalassemia trait in a Brazilian population. Hematology. 2013 May 1;18(3):169-74. https://doi.org/10.1179/1607845412Y.0000000054 PMid:23321282

10. Iolascon A, Andolfo I, Russo R, Sanchez M, Busti F, Swinkels D, Aguilar Martinez P, Bou‐Fakhredin R, Muckenthaler MU, Unal S, Porto G. Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia. Hemasphere. 2024; 8(7):e108. https://doi.org/10.1002/hem3.108 PMid:39011129 PMCid:PMC11247274

11. Obeagu EI, Obeagu GU, Chukwueze CM, Ikpenwa JN, Ramos GF. Evaluation of protein C, protein S and fibrinogen of pregnant women with malaria in Owerri metropolis. Madonna University journal of Medicine and Health Sciences ISSN: 2814-3035. 2022 Apr 19;2(2):1-9.

12. Obeagu EI, Obeagu GU. Neonatal Outcomes in Children Born to Mothers with Severe Malaria, HIV, and Transfusion History: A Review. Elite Journal of Nursing and Health Science, 2024; 2(3): 38-58

13. Sahli CA, Bibi A, Ouali F, Fredj SH, Dakhlaoui B, Othmani R, Laouini N, Jouini L, Ouenniche F, Siala H, Touhami I. Red cell indices: differentiation between β-thalassemia trait and iron deficiency anemia and application to sickle-cell disease and sickle-cell thalassemia. Clinical Chemistry and Laboratory Medicine (CCLM). 2013; 51(11):2115-24. https://doi.org/10.1515/cclm-2013-0354 PMid:23800659

14. Hoffmann JJ, Nabbe KC, van den Broek NM. Effect of age and gender on reference intervals of red blood cell distribution width (RDW) and mean red cell volume (MCV). Clinical Chemistry and Laboratory Medicine (CCLM). 2015; 53(12):2015-9. https://doi.org/10.1515/cclm-2015-0155 PMid:26536583

15. Miftahussurur M, Husada D, Ningtyas WS. Association of shine and LAL index β-thalassemia trait screening results with anaemia and low birth weigh. international journal of nursing and midwifery science (IJNMS). 2023; 7(3):290-296. https://doi.org/10.29082/IJNMS/2023/Vol7/Iss3/543

16. Shahid H, Saleem M, Naseer N, Tabussam S, Aziz A, Ullah S. Evaluation of Srivastava index to distinguishing Beta-Thalassemia Trait from Iron Deficiency. Pakistan Journal of Medical & Health Sciences. 2022;16(05):1225-. https://doi.org/10.53350/pjmhs221651225

17. Vehapoglu A, Ozgurhan G, Demir AD, Uzuner S, Nursoy MA, Turkmen S, Kacan A. Hematological indices for differential diagnosis of Beta thalassemia trait and iron deficiency anemia. Anemia. 2014; 2014(1):576738. https://doi.org/10.1155/2014/576738 PMid:24818016 PMCid:PMC4003757

18. Urrechaga E. Discriminant value of % microcytic/% hypochromic ratio in the differential diagnosis of microcytic anemia. Clinical chemistry and laboratory medicine. 2008;46(12):1752-1758. https://doi.org/10.1515/CCLM.2008.355 PMid:19055451

19. Obeagu EI, Obeagu GU. Impact of Maternal Eosinophils on Neonatal Immunity in HIV- Exposed Infants: A Review. Elite Journal of Immunology, 2024; 2(3): 1-18 https://doi.org/10.22270/ajdhs.v4i2.82